Literature DB >> 19265193

p53 acetylation is crucial for its transcription-independent proapoptotic functions.

Hirohito Yamaguchi1, Nicholas T Woods, Landon G Piluso, Heng-Huan Lee, Jiandong Chen, Kapil N Bhalla, Alvaro Monteiro, Xuan Liu, Mien-Chie Hung, Hong-Gang Wang.   

Abstract

Acetylation of p53 at carboxyl-terminal lysine residues enhances its transcriptional activity associated with cell cycle arrest and apoptosis. Here we demonstrate that p53 acetylation at Lys-320/Lys-373/Lys-382 is also required for its transcription-independent functions in BAX activation, reactive oxygen species production, and apoptosis in response to the histone deacetylase inhibitors (HDACi) suberoylanilide hydroxamic acid and LAQ824. Knock-out of p53 markedly reduced HDACi-induced apoptosis. Unexpectedly, expression of transactivation-deficient p53 variants sensitized p53-null cells to HDACi-mediated BAX-dependent apoptosis, whereas knockdown of endogenous mutant p53 in cancer cells reduced HDACi-mediated cytotoxicity. Evaluation of the mechanisms controlling this response led to the discovery of a novel interaction between p53 and Ku70. The association between these two proteins was acetylation-independent, but acetylation of p53 could prevent and disrupt the Ku70-BAX complex and enhance apoptosis. These results suggest a new mechanism of acetylated p53 transcription-independent regulation of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19265193      PMCID: PMC2670122          DOI: 10.1074/jbc.M809268200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  Role of BAX in the apoptotic response to anticancer agents.

Authors:  L Zhang; J Yu; B H Park; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

3.  Acetylation of p53 inhibits its ubiquitination by Mdm2.

Authors:  Muyang Li; Jianyuan Luo; Christopher L Brooks; Wei Gu
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

4.  Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation.

Authors:  Y Li; T Yokota; V Gama; T Yoshida; J A Gomez; K Ishikawa; H Sasaguri; H Y Cohen; D A Sinclair; H Mizusawa; S Matsuyama
Journal:  Cell Death Differ       Date:  2007-09-21       Impact factor: 15.828

5.  p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.

Authors:  Maciej Pietrzak; Monika Puzianowska-Kuznicka
Journal:  Biol Chem       Date:  2008-04       Impact factor: 3.915

6.  Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation.

Authors:  Avigail D Amsel; Moran Rathaus; Noam Kronman; Haim Y Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

7.  Essential role for caspase-8 in transcription-independent apoptosis triggered by p53.

Authors:  H F Ding; Y L Lin; G McGill; P Juo; H Zhu; J Blenis; J Yuan; D E Fisher
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

8.  Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.

Authors:  L Huang; Y Sowa; T Sakai; A B Pardee
Journal:  Oncogene       Date:  2000-11-23       Impact factor: 9.867

Review 9.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

10.  Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

Authors:  Chang-Shi Chen; Yu-Chieh Wang; Hsiao-Ching Yang; Po-Hsien Huang; Samuel K Kulp; Chih-Cheng Yang; Yen-Shen Lu; Shigemi Matsuyama; Ching-Yu Chen; Ching-Shih Chen
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

View more
  64 in total

1.  Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in the TP53 Axis and Carcinogenesis-Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic.

Authors:  Laila Al-Eryani; Sabine Waigel; Ashish Tyagi; Jana Peremarti; Samantha F Jenkins; Chendil Damodaran; J C States
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 2.  Discovery and mechanism of natural products as modulators of histone acetylation.

Authors:  Lilibeth A Salvador; Hendrik Luesch
Journal:  Curr Drug Targets       Date:  2012-07       Impact factor: 3.465

3.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

4.  Overexpression of Bcl-2-associated death inhibits A549 cell growth in vitro and in vivo.

Authors:  Na Huang; Jing Zhu; Dan Liu; Ya-Lun Li; Bo-Jiang Chen; Yan-Qi He; Kun Liu; Xian-Ming Mo; Wei-Min Li
Journal:  Cancer Biother Radiopharm       Date:  2011-10-19       Impact factor: 3.099

Review 5.  Multiple transcription factor families regulate axon growth and regeneration.

Authors:  Darcie L Moore; Jeffrey L Goldberg
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

6.  Sirtuin Inhibition Induces Apoptosis-like Changes in Platelets and Thrombocytopenia.

Authors:  Sharda Kumari; Susheel N Chaurasia; Manasa K Nayak; Ram L Mallick; Debabrata Dash
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

7.  SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.

Authors:  Ji-Seon Lee; Jeong-Rak Park; Ok-Seon Kwon; Tae-Hee Lee; Ichiro Nakano; Hiroyuki Miyoshi; Kwang-Hoon Chun; Myung-Jin Park; Hong Jun Lee; Seung U Kim; Hyuk-Jin Cha
Journal:  Neuro Oncol       Date:  2014-08-05       Impact factor: 12.300

8.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

9.  The association of AMPK with ULK1 regulates autophagy.

Authors:  Jong Woo Lee; Sungman Park; Yoshinori Takahashi; Hong-Gang Wang
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 10.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.